• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgG4相关性疾病合并PLA2R相关性膜性肾病:一例报告。

IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report.

作者信息

Huang Meichun, Liu Jun, Li Xiuxiu

机构信息

Renal Department, Tongde Hospital of Zhejiang Province, No. 234 Gucui Road, Hangzhou, 310012, China.

Renal Department, Tongde Hospital of Zhejiang Province, Hangzhou, 310012, China.

出版信息

Open Life Sci. 2024 Jul 25;19(1):20220921. doi: 10.1515/biol-2022-0921. eCollection 2024.

DOI:10.1515/biol-2022-0921
PMID:39071497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11282913/
Abstract

IgG4-related tubulointerstitial nephritis (IgG4-related TIN) is the prevalent clinical manifestation of IgG4-related diseases (IgG4-RD). However, there are limited cases of IgG4-RD occurring with membranous nephropathy (MN) in the absence of phospholipase A2 receptor (PLA2R). There have been no indications of treatment using . This study reported a rare case of IgG4-RD with PLA2R-associated MN without any of the distinct IgG4-related TIN. The patient was treated effectively with . A 71-year-old patient was admitted to the medical facility after presenting with a 1 month history of edema and 8 months of albuminuria. The renal biopsy tissue examination confirmed the presence of MN (phase II) in the absence of pathological manifestations of IgG4-related TIN. Immunohistochemistry identified PLA2R++ (granular capillaries). The serum PLA2R antibody titer was 1:180 (1:20). The patient met the diagnosis with IgG4-RD. Over 8 years of follow-up, the patient was effectively treated with low-dose hormones and , without any adverse effects. This MN is considered a unique form of IgG4-RD, regardless of whether PLA2R antibodies are present or not. Research suggests that could be a promising option for elderly people with IgG4-related MN, as it has been found to have fewer adverse effects.

摘要

IgG4相关性肾小管间质性肾炎(IgG4相关性TIN)是IgG4相关性疾病(IgG4-RD)的常见临床表现。然而,在无磷脂酶A2受体(PLA2R)的情况下,IgG4-RD合并膜性肾病(MN)的病例有限。目前尚无使用……进行治疗的指征。本研究报告了一例罕见的IgG4-RD合并PLA2R相关性MN且无任何典型IgG4相关性TIN表现的病例。该患者接受……治疗后效果良好。一名71岁患者因出现1个月的水肿病史和8个月的蛋白尿入院。肾活检组织检查证实存在MN(II期),无IgG4相关性TIN的病理表现。免疫组化显示PLA2R++(颗粒状毛细血管)。血清PLA2R抗体滴度为1:180(1:20)。该患者符合IgG4-RD的诊断。经过8年多的随访,该患者接受低剂量激素和……治疗效果良好,无任何不良反应。这种MN被认为是IgG4-RD的一种独特形式,无论是否存在PLA2R抗体。研究表明,……对于患有IgG4相关性MN的老年人可能是一个有前景的选择,因为已发现其不良反应较少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c457/11282913/ddb6afa35a12/j_biol-2022-0921-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c457/11282913/50a44885b352/j_biol-2022-0921-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c457/11282913/a37f8d84c0fb/j_biol-2022-0921-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c457/11282913/42d7f196ae30/j_biol-2022-0921-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c457/11282913/ddb6afa35a12/j_biol-2022-0921-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c457/11282913/50a44885b352/j_biol-2022-0921-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c457/11282913/a37f8d84c0fb/j_biol-2022-0921-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c457/11282913/42d7f196ae30/j_biol-2022-0921-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c457/11282913/ddb6afa35a12/j_biol-2022-0921-fig004.jpg

相似文献

1
IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report.IgG4相关性疾病合并PLA2R相关性膜性肾病:一例报告。
Open Life Sci. 2024 Jul 25;19(1):20220921. doi: 10.1515/biol-2022-0921. eCollection 2024.
2
PLA2R-Negative Membranous Nephropathy Presenting as a Prodrome of IgG4-Related Autoimmune Pancreatitis.以IgG4相关性自身免疫性胰腺炎前驱症状表现的PLA2R阴性膜性肾病
Case Rep Nephrol Dial. 2019 Jun 26;9(2):85-91. doi: 10.1159/000501260. eCollection 2019 May-Aug.
3
Phospholipase A2 receptor-associated membranous nephropathy in a patient with IgG4-related disease: A case report.IgG4相关性疾病患者的磷脂酶A2受体相关膜性肾病:一例报告
Medicine (Baltimore). 2019 May;98(20):e15616. doi: 10.1097/MD.0000000000015616.
4
PLA2R-positive membranous nephropathy in IgG4-related disease.IgG4 相关疾病中的 PLA2R 阳性膜性肾病。
BMC Nephrol. 2024 Feb 23;25(1):66. doi: 10.1186/s12882-024-03511-3.
5
A Case of M-Type Phospholipase A2 Receptor-Associated Membranous Nephropathy With IgG4-Positive Cells Infiltration in the Interstitium.1例伴有间质IgG4阳性细胞浸润的M型磷脂酶A2受体相关膜性肾病
Clin Med Insights Case Rep. 2022 Feb 23;15:11795476221078635. doi: 10.1177/11795476221078635. eCollection 2022.
6
Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.膜性肾病患者中磷脂酶A2受体及IgG4的表达
Vasc Health Risk Manag. 2018 May 29;14:103-108. doi: 10.2147/VHRM.S160883. eCollection 2018.
7
IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor.IgG4相关性疾病与抗磷脂酶A2受体抗体无关。
Int J Rheumatol. 2012;2012:139409. doi: 10.1155/2012/139409. Epub 2012 May 10.
8
A cohort study of membranous nephropathy, primary or secondary.膜性肾病的队列研究,原发性或继发性。
BMC Nephrol. 2021 Apr 19;22(1):138. doi: 10.1186/s12882-021-02338-6.
9
Combined membranous nephropathy and tubulointerstitial nephritis as a rare renal manifestation of IgG4-related disease: a case-based literature review.IgG4相关疾病罕见的肾脏表现——膜性肾病合并肾小管间质性肾炎:基于病例的文献综述
CEN Case Rep. 2018 May;7(1):137-142. doi: 10.1007/s13730-018-0311-8. Epub 2018 Feb 1.
10
Phospholipase A2 receptor-negative membranous nephropathy presenting as a rare renal manifestation of IgG4-related disease.磷脂酶A2受体阴性的膜性肾病表现为IgG4相关性疾病罕见的肾脏表现。
SAGE Open Med Case Rep. 2024 Aug 31;12:2050313X241279696. doi: 10.1177/2050313X241279696. eCollection 2024.

本文引用的文献

1
Proliferative features of IgG4-related disease.IgG4相关疾病的增殖特征。
Lancet Rheumatol. 2024 Jul;6(7):e481-e492. doi: 10.1016/S2665-9913(24)00022-5. Epub 2024 Apr 1.
2
A Case of Castleman's Disease with a Marked Infiltration of IgG4-Positive Cells in the Renal Interstitium.一例肾间质中IgG4阳性细胞显著浸润的Castleman病
Diagnostics (Basel). 2024 Feb 23;14(5):476. doi: 10.3390/diagnostics14050476.
3
Review of molecular biological research on the treatment of membranous nephropathy with Tripterygium glycosides based on TCM theory.
基于中医理论的雷公藤苷治疗膜性肾病的分子生物学研究述评。
Medicine (Baltimore). 2023 Nov 10;102(45):e34686. doi: 10.1097/MD.0000000000034686.
4
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification.梅奥诊所膜性肾病共识报告:提出一种新的分类建议。
Kidney Int. 2023 Dec;104(6):1092-1102. doi: 10.1016/j.kint.2023.06.032. Epub 2023 Oct 5.
5
Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis.雷公藤多苷治疗特发性膜性肾病的疗效与安全性:一项基于贝叶斯Meta分析的系统评价
Front Pharmacol. 2023 Aug 2;14:1183499. doi: 10.3389/fphar.2023.1183499. eCollection 2023.
6
Novel Antigens and Clinical Updates in Membranous Nephropathy.膜性肾病的新型抗原和临床进展。
Annu Rev Med. 2024 Jan 29;75:219-332. doi: 10.1146/annurev-med-050522-034537. Epub 2023 Aug 8.
7
IgG4-Related Kidney Disease.IgG4相关性肾病
Clin J Am Soc Nephrol. 2023 Aug 1;18(8):994-996. doi: 10.2215/CJN.0000000000000235. Epub 2023 Jul 7.
8
Triptolide regulates the balance of Tfr/Tfh in lupus mice.雷公藤内酯醇调节狼疮小鼠中 Tfr/Tfh 的平衡。
Adv Rheumatol. 2023 Jul 5;63(1):29. doi: 10.1186/s42358-023-00311-5.
9
Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of (Lév.) Hutch Against IgA Nephropathy.网络药理学及实验验证探讨昆明山海棠(Lév.) Hutch 靶向 PTEN 是其治疗 IgA 肾病的潜在机制。
Drug Des Devel Ther. 2023 Mar 23;17:887-900. doi: 10.2147/DDDT.S402503. eCollection 2023.
10
Remission Induction of IgG4-related Membranous Nephropathy with Multitarget Therapy.多靶点治疗诱导 IgG4 相关膜性肾病缓解。
Intern Med. 2023 Nov 1;62(21):3175-3181. doi: 10.2169/internalmedicine.1023-22. Epub 2023 Mar 15.